Hyloris Pharmaceuticals SA (LON:0AB6)
London
· Delayed Price · Currency is GBP · Price in EUR 6.60
0.00 (0.00%)
At close: Apr 22, 2025
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of 151.71 million as of April 24, 2025. Its market cap has decreased by -48.38% in one year.
Market Cap
151.71M
Enterprise Value
132.64M
Revenue
8.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.60
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 224.34M to 151.71M, a decrease of -32.38%. That is a compound annual growth rate of -7.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 155.24M | 2.51% |
| Dec 31, 2024 | 151.44M | -51.12% |
| Dec 29, 2023 | 309.80M | 12.35% |
| Dec 30, 2022 | 275.75M | -26.54% |
| Dec 31, 2021 | 375.35M | 70.71% |
| Dec 31, 2020 | 219.88M | -1.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.68B |
| HSBC Holdings | 148.30B |
| Shell | 146.96B |
| Unilever | 120.20B |
| Rio Tinto Group | 77.78B |
| RELX PLC | 72.64B |
| British American Tobacco p.l.c. | 69.69B |
| Rolls-Royce Holdings | 60.92B |